Sector: Pharmaceuticals & Biotechnology
|Small Cap
Zim Laboratories Ltd.
₹99.45
₹98.01
₹102.50
₹59.31
₹127.00
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 102.85 | 107.81 | 88.39 | 71.43 | 108.52 |
| Operating Expense | 96.28 | 95.31 | 82.22 | 67.09 | 93.28 |
| Operating Profit | 6.58 | 12.50 | 6.17 | 4.33 | 15.24 |
| Depreciation | 4.90 | 4.85 | 4.83 | 4.79 | 5.23 |
| Interest | 3.31 | 3.43 | 3.16 | 3.30 | 2.91 |
| Tax | 1.24 | 1.67 | 0.11 | -0.59 | 3.23 |
| Net Profit | 3.28 | 4.26 | 0.12 | -1.69 | 5.42 |
₹99.45
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 33.3 | 33.3 | 33.3 | 33.3 | 33.3 | 30.4 |
| FII | 0.2 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.1 |
| Public | 66.3 | 66.5 | 66.5 | 66.5 | 66.5 | 69.6 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 70.65 K | 70.65 K | 100.00% |
| Week | 58.99 K | 58.99 K | 100.00% |
| 1 Month | 82.81 K | 1.38 L | 59.99% |
| 6 Month | 51.31 K | 83.11 K | 61.74% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Turnaround Potential (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2019 | 0.5 | FINAL | Equity Share | |
| 03 Sep, 2018 | 1 | FINAL | 04 Sep, 2018 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹492.90 | ₹6.40 | ₹131.01 | ₹13.79 | ₹559.75 | ₹852.80 |
| % Change | 1.27% | -2.14% | 0.71% | -0.86% | 0.46% | 0.53% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | - | ₹502.55 | ₹1,630.02 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | - | ₹57.92 | ₹140.92 |
| PE TTM | - | -1.50 | 34.50 | - | 28.10 | 34.70 |
| 1 Year Return | 24.95 | 544 | 4.98 | 51.43 | -21.64 | -3.98 |
| ROCE | 3.56 | -5.63 | - | - | 23.87 | 15.27 |
Valiant Laboratories Ltd.
₹ 78.00
+1.46%
Sigachi Industries Ltd.
₹ 20.34
-0.05%
Windlas Biotech Ltd.
₹ 784.40
-0.70%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Solara Active Pharma Sciences Ltd.
₹ 556.00
+1.44%
Medico Remedies Ltd.
₹ 48.93
+2.28%
Dishman Carbogen Amcis Ltd.
₹ 198.45
+1.58%
Lasa Supergenerics Ltd.
₹ 8.07
+1.00%
Advanced Enzyme Technologies Ltd.
₹ 376.50
+0.36%
Bajaj Healthcare Ltd.
₹ 302.20
-1.10%
Ortin Global Ltd.
₹ 15.06
-
Brooks Laboratories Ltd.
₹ 56.41
+4.99%
RPG Life Sciences Ltd.
₹ 2243.00
-2.22%
Bafna Pharmaceuticals Ltd.
₹ 135.50
+0.35%
Alpa Laboratories Ltd.
₹ 67.85
-1.89%
SMS Pharmaceuticals Ltd.
₹ 371.45
-2.62%
Nectar Lifesciences Ltd.
₹ 12.03
-0.25%
Mangalam Drugs and Organics Ltd.
₹ 29.01
-1.36%
Indoco Remedies Ltd.
₹ 195.70
-1.70%
Ind-Swift Laboratories Ltd.
₹ 133.00
+0.92%
Lincoln Pharmaceuticals Ltd.
₹ 722.00
-1.65%
Panacea Biotec Ltd.
₹ 419.90
+0.32%
Medicamen Biotech Ltd.
₹ 268.35
-0.45%
By signing up I certify terms, conditions & privacy policy